These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17448421)

  • 1. Decompensation of chronic heart failure associated with pregabalin in patients with neuropathic pain.
    Murphy N; Mockler M; Ryder M; Ledwidge M; McDonald K
    J Card Fail; 2007 Apr; 13(3):227-9. PubMed ID: 17448421
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible heart failure exacerbation associated with pregabalin: case discussion and literature review.
    Page RL; Cantu M; Lindenfeld J; Hergott LJ; Lowes BD
    J Cardiovasc Med (Hagerstown); 2008 Sep; 9(9):922-5. PubMed ID: 18695430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decompensation of chronic heart failure associated with pregabalin in a 73-year-old patient with postherpetic neuralgia: a case report.
    De Smedt RH; Jaarsma T; van den Broek SA; Haaijer-Ruskamp FM
    Br J Clin Pharmacol; 2008 Aug; 66(2):327-8. PubMed ID: 18507657
    [No Abstract]   [Full Text] [Related]  

  • 4. Possible heart failure associated with pregabalin use: case report.
    Erdoğan G; Ceyhan D; Güleç S
    Agri; 2011 Apr; 23(2):80-3. PubMed ID: 21644108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.
    Sabatowski R; Gálvez R; Cherry DA; Jacquot F; Vincent E; Maisonobe P; Versavel M;
    Pain; 2004 May; 109(1-2):26-35. PubMed ID: 15082123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
    Tassone DM; Boyce E; Guyer J; Nuzum D
    Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregabalin in restless legs syndrome with and without neuropathic pain.
    Sommer M; Bachmann CG; Liebetanz KM; Schindehütte J; Tings T; Paulus W
    Acta Neurol Scand; 2007 May; 115(5):347-50. PubMed ID: 17489946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pregabalin: new therapeutic contributions of calcium channel alpha2delta protein ligands on epilepsy and neuropathic pain].
    Horga de la Parte JF; Horga A
    Rev Neurol; 2006 Feb 16-28; 42(4):223-37. PubMed ID: 16521062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, open-label, multicentre study of pregabalin in the treatment of neuropathic pain in Latin America.
    Xochilcal-Morales M; Castro EM; Guajardo-Rosas J; Obregón TN; Acevedo JC; Chucan JM; Plancarte-Sanchez R; Davila G; Wajsbrot D; Guerrero M; Vinueza R
    Int J Clin Pract; 2010 Aug; 64(9):1301-9. PubMed ID: 20487048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported outcomes in subjects with neuropathic pain receiving pregabalin: evidence from medical practice in primary care settings.
    Navarro A; Saldaña MT; Pérez C; Torrades S; Rejas J
    Pain Med; 2010 May; 11(5):719-31. PubMed ID: 20345618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pregabalin in the treatment of neuropathic pain].
    Vecht CJ
    Ned Tijdschr Geneeskd; 2007 Sep; 151(36):2017; author reply 2017-8. PubMed ID: 17953178
    [No Abstract]   [Full Text] [Related]  

  • 12. [Retrospective evaluation of pregabalin for cancer-related neuropathic pain].
    Baba M; Gomyo I
    Masui; 2012 Feb; 61(2):147-54. PubMed ID: 22413436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled-release oxycodone and pregabalin in the treatment of neuropathic pain: results of a multicenter Italian study.
    Gatti A; Sabato AF; Occhioni R; Colini Baldeschi G; Reale C
    Eur Neurol; 2009; 61(3):129-37. PubMed ID: 19092248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregabalin in the treatment of refractory neuropathic pain: results of a 15-month open-label trial.
    Stacey BR; Dworkin RH; Murphy K; Sharma U; Emir B; Griesing T
    Pain Med; 2008 Nov; 9(8):1202-8. PubMed ID: 18346060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregabalin: new drug. Very similar to gabapentin.
    Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and tolerability of pregabalin in patients with neuropathic pain. Observational study under clinical practice conditions].
    Mallison R; Tilke C; Brasser M; Pittrow D
    MMW Fortschr Med; 2007 Apr; 149(14):46. PubMed ID: 17668764
    [No Abstract]   [Full Text] [Related]  

  • 17. Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study.
    Solak Y; Biyik Z; Atalay H; Gaipov A; Guney F; Turk S; Covic A; Goldsmith D; Kanbay M
    Nephrology (Carlton); 2012 Nov; 17(8):710-7. PubMed ID: 22909343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study.
    Tölle T; Freynhagen R; Versavel M; Trostmann U; Young JP
    Eur J Pain; 2008 Feb; 12(2):203-13. PubMed ID: 17631400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregabalin for peripheral neuropathic pain: results of a multicenter, non-comparative, open-label study in Indian patients.
    LYRICA Study Group
    Int J Clin Pract; 2006 Sep; 60(9):1060-7. PubMed ID: 16939547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Decompensation of a chronic heart failure associated with pregabalin in a 84-year-old patient: a case report].
    Roy M; Chol C; Guy C; Chaneliere AF; Cornillon D; Marsille F; Beyens MN; Mounier G; Blanchon MA
    Therapie; 2011; 66(1):87-8. PubMed ID: 23189341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.